CEO Ariel Cao and I tremendously enjoyed the New Horizons Forum at the annual Glaucoma 360 meeting organized by the Glaucoma Research Foundation. It was a great opportunity to catch up with the industry. It was invigorating to have discussion with such innovative-minded thought leaders.
One of the key takeaways from the meeting was the traction that continuous IOP monitoring has been gaining in establishing the paradigm’s clinical utility. It was motivating to see that clinicians and patients are envisioning a future where the patient is put in the center of glaucoma care empowered by continuous IOP data outside of the clinician’s office.
We would like to extend many thanks to: Adrienne Graves, Dr. Andrew Iwach, Dr. Barbara Wirostko, Meghan Vita, Dr. Ike Ahmed, Dr. Tosin Smith, Dr. Paul Singh, Dr. Sheybani Arsham, Richie Kahn, Ammad Khan, Dr. Jason Bacharach, and many more.
